Day: September 6, 2023

BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today announced that Jason Park, the Company’s Chief Financial Officer, will participate in the following event:The Bank of America 2023 Gaming and Lodging Conference. The fireside chat is scheduled for 3:20PM ET on September 7, 2023.Registration and the live audio portion of the Bank of America 2023 Gaming and Lodging Conference can be accessed at the conference website or at DraftKings’ Investor Relations website. About DraftKings DraftKings Inc. is a digital sports entertainment and gaming company created to fuel the competitive spirit of sports fans with products that range across daily fantasy, regulated gaming and digital media. Headquartered in Boston, and launched in 2012 by Jason Robins, Matt Kalish and Paul Liberman,...

BETHESDA, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, today provided an update regarding the impact of the Maui wildfires and other recent weather events on its hotels and the communities where they operate. As the largest hotel real estate owner on Maui with a presence for over 20 years, Host Hotels & Resorts shares a deep connection to the island’s people and culture. Lahaina has long been revered as a sacred place and home to some of the island’s most precious historical and cultural assets. The August wildfires touched everyone on the island and the Company’s hotels are partnering together to support the safety and wellbeing of the Maui community. The Company’s hotels are providing food and shelter for...

EDISON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-assisted therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”), and other chronic diseases, announced that Stephen Harrison, M.D., has been appointed as Consultant Medical Director. Dr. Harrison, the current Chairman of Hepion’s Scientific Advisory Board (“SAB”), succeeds Todd Hobbs, M.D., who has provided notice to the Company of his resignation as Chief Medical Officer, effective September 29, 2023. Dr. Harrison previously served as Hepion’s Consultant Medical Director from October 2019 until February 2021. He is currently a Visiting Professor of Hepatology at the Radcliffe...

DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Tony Bihl, interim chief executive officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, September 13, 2023, at 8:50 a.m. ET. A live audio webcast of the fireside chat will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event. About BioventusBioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative...

Atlanta, GA, Sept. 06, 2023 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended July 31, 2023 on Wednesday September 13, 2023 after the close of the financial markets. The Company will conduct a conference call on Thursday, September 14, 2023, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join by phone by dialing 877-407-8291. Following the conference call, management will host 1×1 meetings at the Lake Street Capital Markets 7th...

HighlightsLower volume in the Packaging and Printing Sectors, partially offset by the positive impact of actions implemented to adjust our cost structure. Revenues of $706.7 million for the quarter ended July 30, 2023; operating earnings of $39.2 million; and net earnings attributable to shareholders of the Corporation of $20.9 million ($0.24 per share). Adjusted operating earnings before depreciation and amortization(1) of $107.9 million for the quarter ended July 30, 2023; adjusted operating earnings(1) of $70.2 million; and adjusted net earnings attributable to shareholders of the Corporation(1) of $44.0 million ($0.51 per share). On August 22, 2023, announced a major investment to accelerate the commercialization of innovative recyclable flexible packaging.(1) Please refer to the section entitled “Non-IFRS Financial Measures”...

SCOTTSDALE, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced the company intends to restate previously issued audited financial statements as of and for the year ending December 31, 2022 contained in the Annual Report on Form 10-K for the year ended December 31, 2022 and the unaudited interim financial statements contained in the Quarterly Reports on Form 10-Q for the quarters and cumulative periods ended June 30, 2022, and September 30, 2022 (the “Previously Issued Financial Statements”) related to the reacquisition of regional developer rights and transfer pricing adjustments for the Company’s variable interest entities. Background and Determination The Company enters into agreements with its regional developers (the “RD Agreements”)....